Scarica l'app Stockscreener
172.51
0.79%
-1.37
Dopo l'orario di chiusura:
172.51
Repligen Corp Borsa (RGEN) Ultime notizie
RGEN5964422 Bond Profile: Coupon and Redemption - TradingView
Repligen Corp (BSP:R2GE34) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Is It Too Late to Buy Repligen Corp (RGEN) After 6.1% Rally? GF Value Says Undervalued - GuruFocus
Repligen Corp (RGEN) Insider Trading Activity | Apple Insider Buys and Sells - GuruFocus
Repligen Corporation (RGEN) Stock Forecasts - Yahoo Finance
A 700-share stock grant joins options with a $174.86 exercise price for Repligen (RGEN)’s chief product officer. - Stock Titan
Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus
One holder reports no voting power in Repligen (RGEN), despite a 7.36M-share passive stake. - Stock Titan
Repligen CEO Olivier Loeillot sells $1.03m of company stock By Investing.com - Investing.com Nigeria
Repligen Corp (RGEN) CEO Olivier Loeillot Sells 5,535 Shares - GuruFocus
Repligen Corp (RGEN) Shares Fall 7.7% -- What GF Score of 85 Tel - GuruFocus
Repligen CEO Olivier Loeillot sells $1.03m of company stock - Investing.com
Repligen (RGEN) CEO sells shares at $190 and $178.75 under a preset trading plan. - Stock Titan
Repligen Closes BioLife Solutions Acquisition - Yahoo Finance
Repligen completes acquisition of BioLife Solutions - Investing.com
18 commercially approved therapies are supported by BioLife's cell-preserving media. Repligen completed the deal. - stocktitan.net
Repligen Completes Acquisition of BioLife Solutions - Yahoo Finance
Form 144 REPLIGEN CORP For: 5 October By Investing.com - Investing.com South Africa
Repligen Corp (RGEN) Stock Up 4.3% but GF Value Says Overvalued -- GF Score: 85/100 - GuruFocus
Loeillot proposes selling 4,202 Repligen (RGEN) shares through Fidelity. - stocktitan.net
For stock-grant taxes, Repligen (RGEN) withholds 1,248 CEO shares at $181.70 each. - stocktitan.net
Form 144 REPLIGEN CORP For: 5 October By Investing.com - Investing.com Nigeria
1,333 shares vested October 2 are proposed for sale at Repligen (NASDAQ: RGEN). - stocktitan.net
BioLife Solutions Shareholders Approve Repligen Merger Agreement - Yahoo Finance
REPLIGEN CORP. R (RGN.MU) Q1 FY2026 earnings call transcript - Yahoo Finance
Repligen Corporation (RGEN) Options Chain - Yahoo! Finance Canada
Repligen Corporation (RGEN) Options Chain - Yahoo! Finance Canada
A Look at Repligen Corp (RGEN) After 7.8% Decline -- GF Value $1 - GuruFocus
Continuous Bioprocessing Technologies MarketGlobal Forecast 2026-2031 | Market to Reach USD 8.5 Billion as Automation and Biologics Demand Fuel 12.1% CAGR - GlobeNewswire Inc.
Repligen stock price target reaffirmed at $225 by UBS on growth outlook - Investing.com South Africa
Repligen stock price target reaffirmed at $225 by UBS on growth outlook - Investing.com UK
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? - TradingView
After a stock-unit release, Repligen (RGEN) withheld 421 shares from its CFO to cover taxes. - Stock Titan
Repligen CEO Olivier Loeillot sells $976,680 in company stock - Investing.com
Repligen CEO Loeillot sells $2.46m in shares - Investing.com
Repligen Corp (RGEN) CEO Olivier Loeillot Sells 12,946 Shares - GuruFocus
Repligen (RGEN) CEO sells shares at $190 each after exercising options under a trading plan. - Stock Titan
Form 144 REPLIGEN CORP For: 24 September By Investing.com - Investing.com Nigeria
Repligen Corporation (RGEN) Stock Forecasts - finance.yahoo.com
Is Repligen Corp (RGEN) Overvalued After 3.3% Rally? GF Value Sa - GuruFocus
Shares valued at $2.46 million are listed for sale by a Repligen (NASDAQ: RGEN) officer and director. - Stock Titan
Repligen Corp Stock Baskets - GuruFocus
Repligen Corp (BSP:R2GE34) Stock Price & 30 Year Financial Data - GuruFocus
Repligen Corporation stock hits 52-week high at 188.95 USD - Investing.com
Repligen Corporation stock hits 52-week high at 188.95 USD By Investing.com - Investing.com UK
Repligen Corp (RGEN) CEO Olivier Loeillot Sells 5,426 Shares - GuruFocus
Repligen Corp (RGEN) Stock Up 3.3% but GF Value Says Overvalued -- GF Score: 87/100 - GuruFocus
Repligen (RGEN) CEO sells 5,426 shares under plan - Stock Titan
Repligen Corporation (RGEN) stock price, news, quote and history - Yahoo Finance UK
Alkermes Posts Positive Data From Phase I ADHD Study on ALKS 7290 - Zacks Investment Research
2.16%
1.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):